Kasim Allel
@kasimallel.bsky.social
Working at @ox.ac.uk.
PhD Infectious Diseases @lshtm.bsky.social MSc Health Economics @ucl.ac.uk. ID epidemiologist🦠, Global health advocate🌍 #AMR📈
PhD Infectious Diseases @lshtm.bsky.social MSc Health Economics @ucl.ac.uk. ID epidemiologist🦠, Global health advocate🌍 #AMR📈
Reposted by Kasim Allel
TB & climate change: @who.int report out now, building on an analytical framework we developed to explore the intersections and implications for the TB epidemic. Key message? TB should be considered a climate-sensitive disease www.who.int/publications...
Tuberculosis and climate change: analytical framework and knowledge gaps
This report explores the intersection of tuberculosis (TB) and climate change, highlighting how climate-related challenges such as food and water insecurity, displacement, and disrupted healthcare acc...
www.who.int
May 30, 2025 at 8:30 AM
TB & climate change: @who.int report out now, building on an analytical framework we developed to explore the intersections and implications for the TB epidemic. Key message? TB should be considered a climate-sensitive disease www.who.int/publications...
Reposted by Kasim Allel
The new WHO guideline recommend using the 7-sign IMCI algorithm to detect serious infections in infants, simplified antibiotics when referral isn’t possible, stronger referral systems, and rational antibiotic use to fight #AMR and improve newborn care
#InfectiousDisease
www.who.int/indonesia/ne...
#InfectiousDisease
www.who.int/indonesia/ne...
WHO issues updated guidance on managing serious bacterial infections in infants
The World Health Organization (WHO) has released updated global recommendations to improve diagnosis and treatment of serious bacterial infections (SBIs) in young infants aged 0–59 days, including sep...
www.who.int
April 22, 2025 at 3:41 AM
The new WHO guideline recommend using the 7-sign IMCI algorithm to detect serious infections in infants, simplified antibiotics when referral isn’t possible, stronger referral systems, and rational antibiotic use to fight #AMR and improve newborn care
#InfectiousDisease
www.who.int/indonesia/ne...
#InfectiousDisease
www.who.int/indonesia/ne...
Reposted by Kasim Allel
New reserach
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
www.thelancet.com/journals/lan...
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
www.thelancet.com/journals/lan...
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
The 2024 WHO BPPL is a key tool for prioritising research and development investments
and informing global public health policies to combat AMR. Gram-negative bacteria
and rifampicin-resistant M tuber...
www.thelancet.com
April 15, 2025 at 1:16 PM
New reserach
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
www.thelancet.com/journals/lan...
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
www.thelancet.com/journals/lan...
Reposted by Kasim Allel
Latest iteration of @who.int bacterial priority pathogens list presented by Hatim Sati, now online @thelancetinfdis.bsky.social
www.thelancet.com/journals/lan...
Don't miss the lovely infographic!!
www.thelancet.com/infographics...
www.thelancet.com/journals/lan...
Don't miss the lovely infographic!!
www.thelancet.com/infographics...
Addressing the growing threat of antibiotic and antimicrobial resistance
The WHO Bacterial Priority Pathogens List (WHO BPPL) is instrumental in guiding research and development (R&D), investments, and global policy towards tackling the most urgent antibiotic-resistant (AB...
www.thelancet.com
April 15, 2025 at 10:26 AM
Latest iteration of @who.int bacterial priority pathogens list presented by Hatim Sati, now online @thelancetinfdis.bsky.social
www.thelancet.com/journals/lan...
Don't miss the lovely infographic!!
www.thelancet.com/infographics...
www.thelancet.com/journals/lan...
Don't miss the lovely infographic!!
www.thelancet.com/infographics...
Let’s get it started, ready for another ESCMID 🚀 😊 looking forward to chat and connect with researchers and professionals across the 🌎 #Vienna
#escmid2025 @escmid.bsky.social
#escmid2025 @escmid.bsky.social
April 11, 2025 at 9:43 AM
Let’s get it started, ready for another ESCMID 🚀 😊 looking forward to chat and connect with researchers and professionals across the 🌎 #Vienna
#escmid2025 @escmid.bsky.social
#escmid2025 @escmid.bsky.social
Reposted by Kasim Allel
Hot off the press! 🔥 Our new systematic review digs deep into #TB cluster randomised trials, exploring how contamination can influence results, and offers insights for improving trial design #TBSky #IDSky #MedSky doi-org.ez.lshtm.ac.uk/10.5588/ijtl...
Contamination effects in cluster randomised trials of TB interven...: Ingenta ConnectBACKGROUNDMETHODSRESULTSCONCLUSION
www.ingentaconnect.com
February 4, 2025 at 3:53 PM
Hot off the press! 🔥 Our new systematic review digs deep into #TB cluster randomised trials, exploring how contamination can influence results, and offers insights for improving trial design #TBSky #IDSky #MedSky doi-org.ez.lshtm.ac.uk/10.5588/ijtl...